Compounds > zalcitabine
Page last updated: 2024-08-22

zalcitabine and Angiogenesis, Pathologic

zalcitabine has been researched along with Angiogenesis, Pathologic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baba, M; Ikeuchi, T; Korenaga, H; Osada, Y; Shigeta, S1

Other Studies

1 other study(ies) available for zalcitabine and Angiogenesis, Pathologic

ArticleYear
Anti-angiogenesis agent DS-4152 is a potent and selective inhibitor of HIV-1 replication in vitro.
    AIDS (London, England), 1994, Volume: 8, Issue:1

    Topics: Antiviral Agents; Cell Line; Didanosine; Giant Cells; HIV-1; Humans; Neovascularization, Pathologic; Polysaccharides, Bacterial; Virus Replication; Zalcitabine

1994